XML 71 R61.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Funding Arrangement - Additional Information (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Apr. 30, 2021 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023
Funding Arrangement [Line Items] |  |  |  |  |
Grant income |  | $ 394 | $ 2,464 | $ 520 | $ 3,119
CARB-X Agreement |  |  |  |  |
Funding Arrangement [Line Items] |  |  |  |  |
Grant receivable on unreimbursed, eligible costs incurred |  | 400 |  | 400 |
CARB-X Agreement | Minimum |  |  |  |  |
Funding Arrangement [Line Items] |  |  |  |  |
Potential funding committed by award |  | 11,700 |  | 11,700 |
National Institutes Of Health |  |  |  |  |
Funding Arrangement [Line Items] |  |  |  |  |
Potential funding amount of award to develop vaccine to prevent shingella infections | $ 500 |  | 4,600 |  | $ 4,600
National Institutes Of Health | Maximum |  |  |  |  |
Funding Arrangement [Line Items] |  |  |  |  |
Potential funding period of award to develop vaccine to prevent shingella infections | 5 years |  |  |  | 5 years
Cost Reimbursement Sub-Award Agreement |  |  |  |  |
Funding Arrangement [Line Items] |  |  |  |  |
Grant income |  | $ 400 | $ 2,500 | $ 500 | $ 3,100

X
- Definition Funding arrangement. + References No definition available. + Details
Name: | pcvx_FundingArrangementLineItems
Namespace Prefix: | pcvx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Grant income. + References No definition available. + Details
Name: | pcvx_GrantIncome
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Potential funding amount of award to develop vaccine to prevent infections. + References No definition available. + Details
Name: | pcvx_PotentialFundingAmountOfAwardToDevelopVaccineToPreventInfections
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Potential funding committed by award. + References No definition available. + Details
Name: | pcvx_PotentialFundingCommittedByAward
Namespace Prefix: | pcvx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Potential funding period of award to develop vaccine to prevent infections. + References No definition available. + Details
Name: | pcvx_PotentialFundingPeriodOfAwardToDevelopVaccineToPreventInfections
Namespace Prefix: | pcvx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_GrantsReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=pcvx_CombatingAntibioticResistantBacteriaBiopharmaceuticalAcceleratorAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=pcvx_NationalInstitutesOfHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=pcvx_CostReimbursementSubAwardAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |